Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease

(2021) Yan-fang Hou et al.   Microbiome

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms

(2020) Anna Santaella et al.   BMC Neurology

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

(2020) Ygor Parladore Silva et al.   Frontiers in Endocrinology

Gut microbiome signatures of risk and prodromal markers of Parkinson's disease

(2020) Sebastian Heinzel et al.   ANNALS OF NEUROLOGY

Plasma Short‐Chain Fatty Acids in Patients With Parkinson's Disease

(2020) Chaewon Shin et al.   MOVEMENT DISORDERS

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions

(2020) Federico Baldini et al.   BMC BIOLOGY

Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens

(2020) Zachary D. Wallen et al.   npj Parkinsons Disease

Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease

(2020) Yiwei Qian et al.   BRAIN

Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects

(2020) Qiuhui Xuan et al.   Advanced Science

Fecal and Blood Microbial 16s rRNA Gene Alterations in Chinese Patients with Multiple System Atrophy and Its Subtypes

(2019) Juanjuan Du et al.   Journal of Parkinsons Disease

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

(2019) Velma T.E. Aho et al.   EBioMedicine

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy

(2019) Akio Mori et al.   PLoS One

A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models

(2019) Guadalupe Vidal-Martinez et al.   Journal of Parkinsons Disease

Alterations of the Gut Microbiota in Multiple System Atrophy Patients

(2019) Linlin Wan et al.   Frontiers in Neuroscience

Microbiome changes: an indicator of Parkinson’s disease?

(2019) Caroline Haikal et al.   Translational Neurodegeneration

Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson’s Disease

(2018) Yiwei Qian et al.   Frontiers in Aging Neuroscience

Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism

(2018) Michela Barichella et al.   MOVEMENT DISORDERS

The Gut and Parkinson’s Disease: Hype or Hope?

(2018) Filip Scheperjans et al.   Journal of Parkinsons Disease

Differentiation of atypical Parkinson syndromes

(2017) Günter U. Höglinger et al.   JOURNAL OF NEURAL TRANSMISSION

Altered gut microbiome and metabolome in patients with multiple system atrophy

(2017) Ai Huey Tan et al.   MOVEMENT DISORDERS

The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy

(2017) Phillip A. Engen et al.   Journal of Parkinsons Disease

Fatty acids and their therapeutic potential in neurological disorders

(2016) Enie Lei et al.   NEUROCHEMISTRY INTERNATIONAL

Host microbiota constantly control maturation and function of microglia in the CNS

(2015) Daniel Erny et al.   NATURE NEUROSCIENCE

When DLB, PD, and PSP masquerade as MSA

(2015) Shunsuke Koga et al.   NEUROLOGY

Multiple-System Atrophy

(2015) Alessandra Fanciulli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Multiple system atrophy: current and future approaches to management

(2010) Olivier Flabeau et al.   Therapeutic Advances in Neurological Disorders

Second consensus statement on the diagnosis of multiple system atrophy

(2008) S. Gilman et al.   NEUROLOGY